| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Biomarin Pharmaceutical Inc. (BMRN) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. BMRN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 159.4K | $9.01M | - | |
| VP | 80.0K | $4.52M | - | |
| VP | 55.1K | $3.11M | - | |
| Dir | 49.4K | $2.79M | - | |
| Dir | 46.4K | $2.62M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 27, 2017 | Bienaime Jean Jacques68 | Chief Executive Officer | Sale+OE | 5,000 | $95.72 | $478,600.00 | -2.1% | |
| Apr 25, 2017 | Bienaime Jean Jacques68 | Chief Executive Officer | Sale+OE | 5,000 | $94.00 | $470,000.00 | -2.1% | |
| Mar 29, 2017 | Ajer Jeffrey Robert58 | EVP, Chief Commercial Officer | Sell | 3,890 | $89.15 | $346,793.50 | -7.0% | |
| Mar 16, 2017 | Bienaime Jean Jacques68 | Chief Executive Officer | Sale+OE | 10,000 | $91.69 | $916,900.00 | -2.5% | |
| Mar 16, 2017 | Davis George Eric64 | EVP, General Counsel | Sell | 2,238 | $91.96 | $205,806.48 | -2.9% | |
| Mar 16, 2017 | Spiegelman Daniel K59 | EVP, Chief Financial Officer | Sell | 1,989 | $91.96 | $182,908.44 | -12.1% | |
| Mar 13, 2017 | Bienaime Jean Jacques68 | Chief Executive Officer | Sale+OE | 5,000 | $92.68 | $463,400.00 | -2.4% | |
| Mar 10, 2017 | Bienaime Jean Jacques68 | Chief Executive Officer | Sale+OE | 11,000 | $90.59 | $996,530.00 | -2.6% | |
| Mar 7, 2017 | Ajer Jeffrey Robert58 | EVP, Chief Commercial Officer | Sell | 5,000 | $90.56 | $452,800.00 | -9.7% | |
| Mar 6, 2017 | Spiegelman Daniel K59 | EVP, Chief Financial Officer | Sell | 2,303 | $93.32 | $214,915.96 | -10.0% |